Xu, who also leads Case Western's Center for AI in Drug Discovery, noted that the study's limitations keep it from drawing firm causal conclusions about the links between semaglutide and lowered ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...